API plans to stop manufacturing in New Zealand, resulting in the loss of 150 jobs. The company announced it would focus on its pharmacy distribution and retail businesses in Australia and manufacturing of its personal care and OTC would be outsourced. API said that the impact of COVID-19 and the continual unfavourable ranging decisions by grocery retailers made the decision easier to make.
API Stops Manufacturing in NZ
